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ABSTRACT
Introduction The COVID-19 pandemic has impacted 
specialty chronic obstructive pulmonary disease (COPD) 
care. We examined the degree to which care has moved 
to remote approaches, eliciting clinician and patient 
perspectives on what is appropriate for ongoing remote 
delivery.
Methods Using an online research platform, we 
conducted a survey and consensus- building process 
involving clinicians and patients with COPD.
Results Fifty- five clinicians and 19 patients responded. 
The majority of clinicians felt able to assess symptom 
severity (n=52, 95%), reinforce smoking cessation (n=46, 
84%) and signpost to other healthcare resources (n=44, 
80%). Patients reported that assessing COPD severity and 
starting new medications were being addressed through 
remote care. Forty- three and 31 respondents participated 
in the first and second consensus- building rounds, 
respectively. When asked to rate the appropriateness 
of using remote delivery for specific care activities, 
respondents reached consensus on 5 of 14 items: 
collecting information about COPD and overall health 
status (77%), providing COPD education and developing 
a self- management plan (74%), reinforcing smoking 
cessation (81%), deciding whether patients should seek in- 
person care (72%) and initiating a rescue pack (76%).
Conclusion Adoption of remote care delivery appears 
high, with many care activities partially or completely 
delivered remotely. Our work identifies strengths and 
limitations of remote care delivery.
INTRODUCTION
The COVID-19 pandemic has greatly impacted 
patient care across many settings.1For people 
living with chronic obstructive pulmonary 
disease (COPD) in the UK, the pandemic 
led to limitations in planned and unplanned 
access to specialist care, in both hospital and 
community settings. Such limitations are 
of particular concern for those with severe 
COPD who are considered to be ‘clinically 
extremely vulnerable’.2 The degree to which 
specialty care for COPD has been able to 
continue given the risks associated with face- 
to- face contact, as well as pressures on NHS 
staffing and organisations, is not known; 
anecdotal evidence suggests that rapid adop-
tion of remote care delivery has enabled some 
continuity.
Telehealth is 'the means by which technol-
ogies and related services concerned with 
health and well- being are accessed by people 
or provided for them irrespective of loca-
tion’.3 Telemedicine (a subset of telehealth) 
typically refers to services delivered by health-
care professionals.3–5 There is mixed evidence 
on the provision and impact of telehealth in 
specialist COPD care, in part due to the diver-
sity of services and outcomes evaluated.6 7 
Aspects of telehealth may significantly reduce 
emergency department attendances and 
hospitalisations,7 8 but there is little evidence 
for its effect on mortality,7 8outpatient visits8 
or length of stay.8 The impact of telehealth 
on quality of life in people with COPD is 
uncertain.9
While the UK has been historically slow to 
adopt digital technologies and telehealth,10 
including in COPD,11 the current pandemic 
trajectory suggests that telehealth will have 
an important role for the foreseeable future. 
Recent rapid guidelines set out by National 
Institute for Health and Care Excellence 
(NICE) for COPD care include specific 
modifications to usual care to reduce patient 
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 ► We sought to understand which aspects of routine 
chronic obstructive pulmonary disease (COPD) care 
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ered remotely. There was broad support for assess-
ing symptoms, support for smoking cessation and 
signposting to other services.
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2 Wu F, et al. BMJ Open Resp Res 2021;8:e000817. doi:10.1136/bmjresp-2020-000817
Open access
exposure to COVID-19, including switching to telemed-
icine for routine annual review.12 The guidance leaves 
much room for organisations to determine appropriate 
local policy accounting for their patient population and 
resources. There is little clarity on what good remote 
COPD care should look like, both to substitute and to 
supplement in- person care, and questions remain on 
what can and cannot be effectively and safely delivered 
remotely to maximise high- quality care at a distance. 
Both short- term and long- term changes are needed to 
support and sustain such new care models.13 14
In this study, we sought to better understand the extent 
to which care has moved to using telehealth approaches 
for COPD under specialist community and secondary 
care services in the UK. Our objectives were to conduct 
a survey to understand what is currently happening with 
remote provision of specialty COPD care (eg, telephone, 
video calls and e- mail), to develop consensus among 
clinicians and patients on what aspects of COPD care are 
appropriate for remote approaches, and to understand 
their perspectives on actions needed to improve ongoing 
remote specialty care delivery. We focus on the remote 
delivery of acute and planned care that would ordinarily 
have been delivered face- to- face, rather than remote 
monitoring of symptoms and physiological variables 
which in this context can best be considered an ‘add- on’ 
to usual care and which has generally not been shown to 
be cost- effective.15
METHODS
Our work involved two sequential components: a survey 
of current practices and a consensus- building process.
Survey of current practices
We developed two questionnaires—one for clinicians 
providing specialty COPD care in community and 
secondary care services, and one for patients with COPD. 
The surveys were hosted using Thiscovery ( www. this-
covery. org), a secure online platform developed by THIS 
Institute, which allows members of the public, including 
patients, carers, healthcare professionals and others, to 
engage in research. Both versions of the questionnaire 
included similar closed- ended questions about respond-
ents’ experience of remote specialty care, including the 
mode and content of consultations. We also asked open- 
ended questions covering what worked well and improve-
ments that might be made with regard to remote care 
delivery. The clinician questionnaire included additional 
questions to understand the scope of and support for 
remote care delivery. Questionnaire development drew 
on accepted approaches to design, item construction and 
survey procedures.16 17 In an iterative process, we under-
took successive drafting of questions within the research 
team, informed by pretesting with small advisory groups 
of three patients and three clinicians, before finalising the 
survey instrument. We did not undertake formal piloting, 
but in keeping with questionnaire design principles,16 17 
we used the development process to maximise clarity of 
questions and to ensure that ambiguities were removed.
Questions regarding the scope of current care were 
based on requirements set out in NICE standards for the 
provision of specialty support for people with COPD,12 
including both routine and urgent care. These were cate-
gorised by a clinically qualified member of the research 
team, and developed further in consultation with the 
advisory groups. Based on these discussions, the phrasing 
of each question was tailored for clinician and patient 
versions of the survey (eg, clinicians were asked whether 
they used remote care to ‘reinforce appropriate oxygen 
therapy in the community for patients with COPD’, while 
patients were asked whether remote care was used in 
‘supporting your oxygen treatment’), and only clinicians 
were asked whether they used remote care for urgent 
care tasks. Both groups were asked about their use of 
remote care since the onset of the COVID-19 pandemic. 
Clinicians were also asked questions regarding the extent 
of their use of remote care, the modalities used and the 
existence of standard protocols on their units. In each 
case, categorical responses were provided based on 
consultation within the team and with advisory groups, 
with an ‘other’ category and associated free- text box to 
ensure that unanticipated responses were accounted 
for. Both groups were asked to state what had worked 
well and less well in their experience of remote care, 
again with slightly different question forms based on 
consultation with the advisory groups, using free- text 
response boxes. Questions were also asked regarding 
participants’ demographic characteristics (sex, age and 
ethnicity), using Office for National Statistics categories 
for ethnicity. See online supplemental appendices 1 and 
2 for the questionnaires.
We sought responses from clinicians who provided 
specialty care for patients with COPD, including those 
who were part of respiratory care teams or other relevant 
specialties such as palliative care. For patients, eligibility 
criteria included that they (1) were 18 years or older, (2) 
had been diagnosed with COPD and (3) had accessed 
specialty COPD care in the last 3 months. In both cases, 
participation was limited to UK- based respondents. 
Because of restrictions on accessing NHS or professional 
organisations for research collaboration during the 
COVID-19 pandemic, recruitment primarily took place 
through social media. For clinicians, the British Thoracic 
Society (BTS), the Royal College of Physicians (RCP), the 
National Asthma and COPD Audit Programme (NACAP), 
the Association of Respiratory Nurse Specialists and the 
Association of Chartered Physiotherapists in Respiratory 
Care advertised the survey from their Twitter accounts. In 
addition, BTS, RCP and NACAP advertised through their 
electronic newsletters. For patients, the British Lung 
Foundation posted on Facebook and HealthUnlocked, 
an online forum for people living with various health 
conditions, including COPD.
Univariate summary statistics were calculated for 
closed- ended questions. For open- ended responses, one 
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researcher developed a coding framework based on the 
data and thematically coded all responses; a second inde-
pendently coded 10% (n=13) of the responses according 
to this framework. There was a high degree of agreement 
between the two researchers. Analysis was conducted in R 
(closed- end questions) and Microsoft Excel, 2016 (open- 
ended questions).
Consensus-building process
In the second stage of the project, we undertook a 
consensus- building process to gain understanding of what 
care activities patients and clinicians consider appropriate 
for remote delivery. As with the survey, the process was 
hosted online using Thiscovery. We produced a briefing 
document summarising current evidence from 24 studies 
on the effectiveness of remote care in COPD, to which 
participants in the consensus- building process were given 
access as they participated. The briefing document was 
informed by a rapid literature review which followed 
recommended methods for searching, screening, data 
extraction and synthesis.18–21 In the first round, partici-
pants were asked to rate the appropriateness of deliv-
ering various COPD- related care activities remotely, 
again based on NICE standards,12 using a 9- point scale, 
from 1 (not at all appropriate) to 9 (highly appropriate). 
Care activities related to both planned and unplanned 
specialty care (table 1). In the second round, for care 
activities where consensus was not reached in the first 
round, we asked participants to review and rerate each 
item. In this round, we provided additional information: 
(1) group- level information (clinicians and patients) on 
how other respondents rated that item in the first round; 
and (2) for a subset of care activities, a summary of the 
evidence (based on the briefing document) with regard 
to the effectiveness of remote provision. This two- round 
consensus- building process was broadly based on Delphi 
consensus- development methodology, adapted for 
online administration and for involvement from poten-
tially larger and more diverse groups of stakeholders.22 23 
We defined consensus as at least 70% agreement—that 
is, at least 70% of respondents rating an item 1, 2 or 3 
(consensus on the item being not appropriate) or 7, 8 or 
9 (consensus on the item being appropriate).24 Finally, 
during the second round, we asked participants for their 
views on what should be prioritised to improve remote 
communication for specialty COPD care, using a 5- point 
scale from ‘not at all urgent’ to ‘very urgent’.
For the two consensus development rounds, summary 
statistics were calculated for each item rated. In addition, 
we calculated the frequencies of the ratings and grouped 
frequencies for ratings 1–3, 4–6 and 7–9. Analysis was 
conducted in R.
Patient and public involvement
Patients or the public were not involved in the design, 




Fifty- five clinicians responded to the survey. Fifty- one 
patients initiated the questionnaire, but several had 
not accessed specialty COPD care in the last 3 months; 
19 patients met the eligibility criteria and completed 
Table 1 Specialty COPD care activities included in consensus- building process
Type of care Care activity description
Routine Collecting information about a patient’s COPD and overall health status by asking questions (eg, 
assessing symptoms, understanding recent hospital admissions and assessing needs for various 
services)
Performing a lung function test (breathing in to a spirometer)
Measuring oxygen levels using a finger probe (pulse oximetry)
Assessing how far a patient can walk by doing a walking test (performing an exercise test)
Checking inhalers are used properly
Providing education about COPD or COPD treatment and developing a self- management plan
Supporting a patient to stop smoking (smoking cessation support)
Starting a patient on a new medication
Providing an exercise and education programme (pulmonary rehabilitation)
Having a healthcare professional teach how best to clear sputum/phlegm (airway clearance support)
Having a healthcare professional teach new breathing techniques (breathing training)
Helping a patient make plans around death and dying (advance care planning)
Urgent/unplanned Making a decision on whether a patient needs to see a healthcare professional face- to- face
Helping a patient make a decision on whether to use extra treatment, often called a 'rescue pack'
COPD, chronic obstructive pulmonary disease.
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the consent and questionnaire. Table 2 provides demo-
graphic details.
Clinician respondents provided care in community 
(n=26, 47%), secondary care (n=20, 36%) or integrated 
settings (n=9, 16%). Respondents were mostly nurses 
(n=22, 40%), doctors (n=15, 27%) or physiotherapists 
(n=15, 27%).
Survey results
Most patients reported remote consultation by phone 
only (n=15, 79%), compared with other forms of commu-
nication, including by video only (n=2, 11%), by phone 
and video (n=1, 5%), or by text or online messaging (n=1, 
5%). Remote consultations were typically concerned with 
COPD severity (eg, assessing symptoms, exacerbations, 
lung function and oximetry; n=11, 58%); patients also 
reported discussions concerning starting medication for 
COPD (n=6, 32%) (table 3). A majority of patients found 
remote communication to be helpful or quite helpful 
(n=11, 58%, and n=4, 21%, respectively).
Remote alternatives to routine face- to- race contacts 
were reported to be present in the place of work of 18 
clinicians (33%) prior to the COVID-19 pandemic. Since 
the start of the pandemic, 52 (95%) reported that remote 
alternatives had been instigated. Almost all clinicians 
were now using these methods of contact for more than 
half or all of their patients (n=48, 87%). These remote 
contacts were most commonly by phone (n=40, 73%), 
with 13 (24%) clinicians reporting most communication 
by video or by both phone and video.
Using remote communication, most clinicians reported 
that they were able to assess symptom severity (n=52, 
95%), reinforce smoking cessation (n=46, 84%), signpost 
to other healthcare resources such as self- management 
support (n=44, 80%), and reinforce appropriate oxygen 
therapy (n=40, 80%) (table 3). Most clinicians also used 
remote communication for aspects of unplanned care, 
including determining a patient’s need for hospital 
assessment during an exacerbation (n=34, 62%) or initi-
ating the use of rescue packs (n=39, 71%). Finally, a few 
clinicians reported using remote communication to liaise 
with other clinicians, such as the patient’s primary care or 
inpatient medical team.
Almost half of clinician respondents reported that they 
used a standard tool to assess and record disease severity 
during remote communication (n=25, 45%), and only 
10 (18%) reported regularly using remote physiological 
monitoring of patients at home (table 4). Less than half 
of clinician respondents (n=24, 44%) reported that stan-
dard procedures were in place to support remote commu-
nication in their organisations, and eight (15%) were 
unsure whether any were in place. Finally, the majority of 
clinicians either reported that no protocol was in place 
for hard- to- reach patients, including patients unable to 
use technology (n=30, 55%) or were unsure whether 
such a protocol existed (n=11, 20%).
Answers to open- ended questions indicated that clini-
cians saw many benefits to remote approaches, including 
a way of communicating that avoided the perceived risks 







  Male 12 (22) 5 (26)
  Female 42 (76) 14 (74)
  Not given 1 (2) 0 (0)
Age (years), n (%)
  25–34 8 (15) 0 (0)
  35–44 15 (27) 2 (11)
  45–54 23 (42) 4 (21)
  55–64 7 (13) 7 (37)
  65–74 1 (2) 5 (26)
  75+ 0 (0) 1 (5)
  Not given 1 (2) 0 (0)
Ethnicity, n (%)
  White 48 (87) 19 (100)
  Mixed/multiple ethnic 
groups
0 (0) 0 (0)




  Other ethnic group 0 (0) 0 (0)
  Not given 1 (2) 0 (0)
Table 3 Care activities currently covered remotely, number 






Reinforce smoking cessation 46 (84%) 4 (21%)
Assess symptom severity 52 (95%) 11 (58%)
Initiate medication for COPD 36 (65%) 6 (32%)
Change regular medication for 
COPD
35 (64%) 1 (5%)
Reinforce appropriate oxygen 
therapy
40 (73%) 3 (16%)
Signpost to other online 
healthcare resources
44 (80%) 3 (16%)
Deliver pulmonary rehabilitation 12 (22%) 4 (21%)
Advise on nutrition 27 (49%) 0 (0%)
Support end- of- life care 18 (33%) 0 (0%)
Determine need to admit 
to hospital in relation to 
exacerbation of COPD*
34 (62%) –
Initiate use of rescue packs* 39 (71%) –
*Question asked only in clinician questionnaire.
COPD, chronic obstructive pulmonary disease.
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of coming to the clinic during the pandemic and the 
possibility of prompt, flexible and ongoing contact with 
patients. A few noted how quickly adoption had occurred 
and expressed surprise that a reasonable amount of 
patient needs could be addressed over phone and video. 
However, they expressed a high level of concern about 
patients with limited information technology access and 
the possibility of missing the more nuanced communi-
cation that goes with face- to- face contact, particularly in 
relation to telephone (as opposed to video) contact. The 
majority of patients found remote communication to be 
helpful but, in a few cases, felt they waited a long time 
to get their appointment and were disappointed by the 
limited nature of the communication (table 5).
Consensus building
For the first round of the consensus- building process, 
we invited respondents who had registered for the initial 
survey (n=106). For the second round, we invited only 
those respondents who participated in the first round 
(n=43).
For the first round, participants were asked to rate 14 
items on their appropriateness for remote approaches. 
Twenty- three clinicians and 20 patients participated. 
There was consensus that 5 of the 14 items were appro-
priate for remote approaches, meaning that 70% or 
more of respondents gave a rating of 7, 8 or 9. These 
five items were collecting information about a patient’s 
COPD and overall health status by asking questions 
(77%); providing education about COPD or COPD treat-
ment and developing a self- management plan (74%); 
supporting a patient to stop smoking (81%); making a 
decision on whether a patient needs to see a healthcare 
professional face- to- face (72%); and helping a patient 
decide whether to use a rescue pack (76%) (table 6). 
For no item was there consensus that remote approaches 
were inappropriate (70% or more of respondents giving 
a rating of 1, 2 or 3). Comparison by group showed that 
there were some differences in rating between clinicians 
and patients. For example, clinicians had high agree-
ment that collecting information on patients’ COPD and 
health status was appropriate (85% of clinicians rated it 7, 
8 or 9 compared with 68% of patients). Notably, patients 
had high agreement that performing a lung function test 
(using spirometer) was not appropriate (73% of patients 
rated it either 1, 2 or 3 compared with 50% of clinicians).
Table 5 Quotations from open- ended responses
  Positive aspects of remote care Concerns about remote care
Clinicians ‘We are still able to support patients at home and encourage 
them to keep active despite most of them having to shield. 
We can also ensure their oxygen requirements are catered for 
and if necessary decide to do a home visit’.
‘Almost all aspects of care can be achieved by video, except 
hands on breathing techniques. Patients really appreciate the 
contact, without having to risk infection from face- to- face 
care’.
‘Mostly by phone so parts of assessment it is 
difficult to complete, there is more feedback from 
face- to- face assessment via video’.
‘Our health Trust is very rural and wifi/technology 
signals are poor. Our older age population is not 
technologically minded which will discriminate 
against their ability to link in via video’.
Patients ‘It was very relaxing and the lady made me feel at ease. She 
was very helpful in explaining fully the medication I am on 
and the correct way of taking it. The video call was at the 
precise time as arranged’.
‘I was given advice and medication to help with an 
exacerbation of my COPD. This was also followed up 
regularly to check on my condition’.
‘Doctor could have listened more to ongoing 
problem’.
‘I doubt you could make remote care as good as 
face to face meetings, but they can fill a need for 
discussion and possible change of medication if 
necessary’.
COPD, chronic obstructive pulmonary disease.
Table 4 Remote care delivery practices, number of clinicians responding yes
Activities related to remote care delivery
Clinicians 
(n=55)
Unit has standard procedures to support remote communication with patients with COPD. 25 (45%)
Unit has protocol for hard to reach patients or patients unable to use technology. 14 (25%)
Actively helps patients in contacting clinicians by phone/video/text message outside of regular scheduled 
appointments
42 (76%)
Uses a standard tool to assess and record disease severity of COPD in remote communication 25 (45%)
Routinely uses remote physiological monitoring of patients at home with COPD 10 (18%)
Engages with carers of patients with COPD by remote communication 26 (47%)
COPD, chronic obstructive pulmonary disease.
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The nine items for which consensus was not reached 
were included in the second round of consensus 
building, in which 31 of 43 respondents participated 
(72%), including 15 clinicians and 16 patients. None 
of the items reached consensus after a second round of 
rating. Subgroup analysis again showed rating differences 
between clinician and patient respondents. Whereas 
patients did not achieve consensus on any of the nine 
items, clinicians reached consensus that five items were 
appropriate for remote approaches: checking inhaler 
technique (75%), starting new medication (85%), deliv-
ering pulmonary rehabilitation (85%), providing educa-
tion on airway clearance support (83%) and providing 
breathing training (77%).
Five activities were highlighted by respondents as imme-
diate priorities for improving remote communication 
for specialty COPD (ratings of urgent or very urgent): 
establishing direct telephone access for urgent questions 
(87%); developing new or highlighting existing online 
education on how best to deliver remote consultations 
(81%); expanding video consultation availability for 
healthcare professionals and patients, including training 
and support (87%); providing or loaning pulse oximeters 
for at- home measurement of blood oxygen levels (83%); 
and developing standard guidelines for remote consulta-
tion (80%).
DISCUSSION
Our survey findings suggest that widespread adoption 
of remote care delivery for COPD occurred rapidly in 
response to the COVID-19 pandemic. In the absence of 
national guidance, these innovations were led by clini-
cians and varied in response to local circumstances. For 
some clinical participants, the ability to at least partially 
address many planned and urgent COPD care activi-
ties remotely was unexpected. Perceived benefits from 
remote approaches included the ability to provide some 
type of care continuity in a safe manner, especially for 
patients who were shielding. Activities requiring moni-
toring equipment limited the extent to which specialty 
care could be delivered over the phone or by video call, 
given the major changes in resourcing and organisation 
of care required. In terms of consensus on what activi-
ties are appropriate for ongoing remote care delivery, 
respondents agreed that there are planned activities 
Table 6 Overall ratings for the first and second consensus- building rounds
Care activity









Collecting information on 
patients’ COPD and health 
status
3 (7%) 7 (16%) 33 (77%) – – –
Performing a lung function test 26 (60%) 11 (26%) 6 (14%) 16 (59%) 4 (15%) 7 (26%)
Measuring oxygen levels 10 (23%) 16 (37%) 17 (40%) 5 (18%) 8 (29%) 15 (54%)
Performing an exercise test 17 (40%) 19 (44%) 7 (16%) 10 (36%) 8 (29%) 10 (36%)
Checking inhaler technique 15 (36%) 8 (19%) 19 (45%) 7 (26%) 6 (22%) 14 (52%)
Providing COPD information 
and self- management plan
2 (5%) 9 (21%) 32 (74%) – – –
Supporting smoking cessation 1 (2%) 7 (16%) 35 (81%) – – –
Starting new medication 6 (14%) 12 (28%) 25 (58%) 2 (7%) 8 (29%) 18 (64%)
Providing pulmonary 
rehabilitation
4 (9%) 18 (42%) 21 (49%) 0 (0%) 11 (39%) 17 (61%)
Providing airway clearance 
support
8 (19%) 10 (23%) 25 (58%) 4 (15%) 6 (22%) 17 (63%)
Providing education on 
breathing training
6 (14%) 12 (28%) 25 (58%) 3 (10%) 7 (24%) 19 (66%)
Helping with advance care 
planning
16 (37%) 11 (26%) 16 (37%) 12 (43%) 6 (21%) 10 (36%)
Deciding whether patient 
needs face- to- face care
7 (16%) 5 (12%) 31 (72%) – – –
Deciding whether patient 
should use a rescue pack
7 (17%) 3 (7%) 32 (76%) – – –
Care activities on which consensus about appropriateness was achieved are presented in bold text.
*Ratings group ‘not appropriate’ includes appropriateness ratings of 1, 2 or 3; ‘possibly appropriate’ includes ratings of 4, 5 or 6; 
‘appropriate’ includes ratings of 7, 8 or 9.
COPD, chronic obstructive pulmonary disease.
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(gathering patient information on COPD and health 
status, providing counselling on smoking cessation, and 
providing education on COPD or developing a self- 
management plan) and urgent care activities (triaging 
patients for face- to- face care and initiating use of rescue 
packs) appropriate for remote provision. Subsequent 
rounds of consensus building did not result in agreement 
on other items.
Rating differences were found between clinician and 
patient respondents in sensitivity analyses. While the 
numbers are small, the findings suggest that clinicians and 
patients may have differing views with regard to appro-
priateness of remote care delivery for specialty COPD 
care, reflecting underlying differences in perspectives 
on and preferences for remote healthcare in general. In 
the second round of consensus building, a high propor-
tion of clinicians felt various activities involving remote 
instruction or education were appropriate—checking 
inhaler technique, providing breathing training and 
providing education on airway clearance, for example. 
Lower ratings by patients suggest that they do not share 
the same level of comfort about the appropriateness 
of these activities, or prefer to receive this type of care 
in- person. These differences should be examined more 
closely in future planning and development of remote 
COPD care, including the impact of the medium of 
remote care (eg, video vs telephone contact).
Our findings provide some indication of the level of 
care being provided remotely in the UK and help to 
identify practical next steps to systematically build on 
and sustain current remote practice. Though adoption 
of remote communication was quick and widespread, 
limited provision of equipment, such as pulse oximeters 
and spirometers, for in- home monitoring is a barrier 
to more fully realising benefits of remote care delivery. 
The predominant reliance on telephone- only contact, 
and more limited uptake of video- based technology, 
may also act as a barrier, particularly given the limita-
tions of telephone- based consultation identified by some 
participants.
Findings may help to elaborate on NICE COVID-19 
COPD guidelines12 to describe what new models of 
remote care delivery should look like as NHS organi-
sations need to move from reacting to the pandemic 
to considering the broader role of digital technologies 
in providing care of COPD in systems where capacity 
for face- to- face care may be limited for some time. Our 
study complements BTS provision of rapid guidance25 
by providing both clinician and patient perspectives. 
Further work is required to more fully understand the 
degree to which both planned and unplanned care activi-
ties can safely be carried out remotely in a way acceptable 
to patients and clinicians, what kind of hybrid models can 
be implemented based on patient preferences, new work-
flows that need to be established to coordinate between 
clinicians and across care settings, and critical organisa-
tional investments needed to develop telehealth in mean-
ingful ways.
We identified several potential limitations to the study. 
Given that the survey was online and advertising for our 
survey was primarily through social media channels, the 
responses may not be representative of specialty clini-
cians caring for patients with COPD, or (particularly) of 
patients with COPD themselves, given COPD’s higher 
prevalence among older and socioeconomically disad-
vantaged populations whose access to social media may 
be more limited. Notably, 100% of patient participants in 
the survey gave their ethnicity as ‘white’. We advertised 
the survey through organisations that reach a breadth of 
clinicians and consulted British Lung Foundation (BLF) 
on other avenues through which to reach hard- to- reach 
patient groups. In addition, we experienced attrition 
through the course of the project. Although only 43 of 
106 invited participants took part in the first round of the 
consensus- building exercise (41%), there was 72% reten-
tion between consensus- building rounds. The number of 
participants is not large in relation to the sensitivity anal-
ysis, and so results must be interpreted with appropriate 
caution. A qualitative study of patients’ and clinicians’ 
views would add complementary information.
In this study, we collected data from clinicians and 
patients with COPD using a questionnaire on current 
practice and through a consensus- building process. 
Given constraints arising from the COVID-19 pandemic, 
we used an online research platform rapidly and prag-
matically to identify strengths and limitations of current 
remote care delivery for specialty COPD care. Our find-
ings add evidence on the acceptability of various compo-
nents of remote care delivery, from the perspective of both 
patients and clinicians to existing evidence of impact of 
telehealth in COPD.6 7 Suggestions for improving remote 
care are likely to be of importance even when the current 
pandemic recedes.
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